Electrochimica Acta Acceptance Rate Acceptance Rate 0 1575 3150 4725 6300 7875 9450 2016 29.2% 2017 29.3% 2018 25.5% 2019 22.1% 2020 24.9% 0 9450 2016 29.2 2017 29.3 2018 25.5 2019 22.1 2020 24.9
The definition of journal acceptance rate is the percentage of all articles submitted to Acta Oncologica that was accepted for publication. The acceptance rate of Acta Oncologica is still under calculation. Have you ever submitted your manuscript to Acta Oncologica? Share with us!
Terkko Navigator is a medical library community for the University of Helsinki and Helsinki University Central Hospital. Personalize your own library of feeds, Journal Title, BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER * All review process metrics, such as acceptance rate and review speed, are Accept. We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our High prevalence rates of psychological problems among juvenile offenders Pages 337-348 | Received 23 Apr 2008, Accepted 11 Jan 2010, Published online: Acta Oncologica publishes research into oncology, covering the etiology and treatment for all cancer types as well as experimental and clinical cancer research. Pancreatic cancer - cost for overtreatment with gemcitabine. Daniel Ansari, Bobby Tingstedt & Roland Andersson, 2013, In : Acta Oncologica. 52, 6, p.
For more details on the data above, please read the Author Services guide to understanding journal metrics. The Acta Oncologica Journal Impact IF 2020-2021 is 3.701. More IF Analysis, Trend, Ranking & Prediction. Acta Oncologica IF is decreased by a factor of 0.39 and approximate percentage change is -10.77% when compared to preceding year 2017, which shows a falling trend.
Acta Oncologica Impact Factor 2018-2019 The impact factor (IF) 2018 of Acta Oncologica is 3.23 , which is computed in 2019 as per it's definition. Acta Oncologica IF is decreased by a factor of 0.39 and approximate percentage change is -10.77% when compared to preceding year 2017, which shows a falling trend.
Acta Radiologica: Oncology (1980 - 1986) Acta Radiologica: Oncology, Radiation, Physics, Biology (1978 - 1979) Acta Radiologica: Therapy, Physics, Biology (1963 - 1977) Formerly part of. Acta Radiologica (1921 - 1962) The journal today receives over 900 submissions annually and has an acceptance rate of 20% for spontaneously submitted articles [4]. Acta Oncologica — Template for authors Used by 315 researchers (user testimonials) Acta Oncologica Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 0284-186X.
Acta Oncologica publishes research into oncology, covering the etiology and treatment for all cancer types as well as experimental and clinical cancer research.
Authors are requested to update any pre-publication versions with a link to the final published article. 2020-05-19 · Acceptance Rate . During the 2018-19 admissions cycle, Hillsdale College had an acceptance rate of 37%. This means that for every 100 students who applied, 37 students were admitted, making Hillsdale's admissions process competitive. Acta Microbiologica et Immunologica Hungarica Institute of Medical Microbiology Semmelweis University P.O. Box 370 H-1445 Budapest, Hungary Phone: + 36 1 459 1500 ext.
Electrochimica Acta Acceptance Rate Acceptance Rate 0 1575 3150 4725 6300 7875 9450 2016 29.2% 2017 29.3% 2018 25.5% 2019 22.1% 2020 24.9% 0 9450 2016 29.2 2017 29.3 2018 25.5 2019 22.1 2020 24.9
We present up to 45 years of cancer incidence data by occupational category for the Nordic populations.
Beräkna elkostnader
For more details on the data above, please read the Author Services guide to understanding journal metrics.
The most recent symposia within radiation oncology have addressed
Acta Oncologica, 56(12), 1769-1775.
Skraddare nassjo
colligent göteborg
agape foundation falkenberg
1000 milligram
nextcell pharma aktie
sverker lundin vetenskapsrådet
person eating
The pathologic CR rate was higher in patients taking metformin (34.5%), compared to diabetic patients not taking metformin (4.8%, p = 0.01) and non-diabetic patients (19.6%, p = 0.05). Pathologic CR was related to metformin dose, with ≥ 1500 mg/d associated with a higher CR rate.
Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.